Tor O.
- Country
- Sweden
- Department
- Reumatologi
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Oncology
Focus on advanced solid malignancies and therapeutic strategies to improve outcomes.
- Limited disease small-cell lung cancer
- Advanced epithelial ovarian cancer
- Breast cancer
- Testicular cancer
- Advanced solid tumors
Clinical investigations aim at extending survival and reducing relapse rates.
Hematology
Engagement in malignant hematologic disorders, emphasizing targeted and molecular therapies.
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Chronic lymphocytic leukemia
- Mantle Cell Lymphoma
- VEXAS syndrome
Research addresses disease remission, molecular response, and novel therapeutic agents.
Cardiovascular Medicine
Investigation of acute cardiac events, arrhythmias, and transplant‑related cardiovascular care.
- Acute myocardial infarction complicated by cardiogenic shock
- Atrial fibrillation
- Patients with ST‑Elevation Myocardial Infarction
- Heart transplant
- Reduced noradrenaline use in cardiogenic shock
Studies evaluate mortality, renal outcomes, and anticoagulation strategies.
Reproductive and Gynecologic Health
Focus on post‑abortion contraception timing and peri‑operative care in gynecologic oncology.
- Immediate intrauterine contraception after medical abortion
- Post‑medical abortion contraception
- Fertility preservation in ovarian cancer
Research emphasizes patient‑centered approaches and treatment sequencing.
Immunology & Rare Disorders
Exploration of immune‑mediated and rare inflammatory conditions.
- Fibromyalgia
- Hemophilia A with inhibitory antibodies
- Brain abscess
- Esophageal atresia strictures
- VEXAS syndrome
Investigations target immune modulation, tolerance induction, and novel therapeutic pathways.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.